Search research articles
Contact Us
Filters
Showing results (251-260 of 276) with videos related to
Page
of 28
Sort By:
Frontiers in Oncology
|
October 10, 2022
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Cancer Research
|
February 27, 2009
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
Michael Gobert, Isabelle Treilleux, Nathalie Bendriss-Vermare, et al.
Blood Advances
|
October 23, 2020
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells
Florent Amatore, Nicolas Ortonne, Marc Lopez, et al.
Oncotarget
|
September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Human Pathology
|
April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients
Luc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Oncotarget
|
May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Cancer Research Communications
|
October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Cancer Research
|
April 15, 2022
Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Cancer Research
|
October 10, 2014
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Oncoimmunology
|
September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop
Roch Houot, Philippe Gaulard, Robert Schreiber, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 276) with videos related to
Sort By:
Page
of 28
Frontiers in Oncology
|
October 10, 2022
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Cancer Research
|
February 27, 2009
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
Michael Gobert, Isabelle Treilleux, Nathalie Bendriss-Vermare, et al.
Blood Advances
|
October 23, 2020
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells
Florent Amatore, Nicolas Ortonne, Marc Lopez, et al.
Oncotarget
|
September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Human Pathology
|
April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients
Luc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Oncotarget
|
May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Cancer Research Communications
|
October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Cancer Research
|
April 15, 2022
Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Cancer Research
|
October 10, 2014
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy
Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Oncoimmunology
|
September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop
Roch Houot, Philippe Gaulard, Robert Schreiber, et al.
Page
of 28